CoChat

The DOI matches its Crossref record; 155 of the 155 references it cites were found in a registry or an index.

From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities

Open access
Suthahar, Navin, Meijers, Wouter C., Silljé, Herman H.W., de Boer, Rudolf A. · 2017 · Current Heart Failure Reports

Abstract

PURPOSE OF REVIEW: In this review, we highlight the most important cellular and molecular mechanisms that contribute to cardiac inflammation and fibrosis. We also discuss the interplay between inflammation and fibrosis in various precursors of heart failure (HF) and how such mechanisms can contribute to myocardial tissue remodelling and development of HF. RECENT FINDINGS: Recently, many research articles attempt to elucidate different aspects of the interplay between inflammation and fibrosis. Cardiac inflammation and fibrosis are major pathophysiological mechanisms operating in the failing heart, regardless of HF aetiology. Currently, novel therapeutic options are available or are being developed to treat HF and these are discussed in this review. A progressive disease needs an aggressive management; however, existing therapies against HF are insufficient. There is a dynamic interplay between inflammation and fibrosis in various precursors of HF such as myocardial infarction (MI), myocarditis and hypertension, and also in HF itself. There is an urgent need to identify novel therapeutic targets and develop advanced therapeutic strategies to combat the syndrome of HF. Understanding and describing the elements of the inflammatory and fibrotic pathways are essential, and specific drugs that target these pathways need to be evaluated.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s11897-017-0343-y

Cites

155 of 155 references verified0 citation errors · 0 not checkable

Statistics

Figures

Fig. 1 A simplified depiction of sequence of events in an inflammatory response and the role of proresolution mediators in its termination. Tissue injury elicits an initial vascular response, followed by an influx of neutrophils and monocytes to the damaged area. After reaching the tissue, monocytes transform into macrophages and actively phagocytose the debris. Lymphocytes, which are cells of the adaptive immune system, later modulate this initial response. The basic mechanisms of resolution of inflammation are highlighted which are (1) lipid mediator class switching producing proresolution molecules such as lipoxins and resolvins; (2) increased efferocytosis by macrophages; (3) anti-inflammatory cytokines secreted by “resolving” macrophages and regulatory T cells. Failure to resolve leads to persistence of inflammation resulting in a chronic inflammatory state, causing sustained tissue injury. Adapted figure reproduced from [17] Buckley et al. 2014 with permission from the authors. PGE2, prostaglandin E2; PGI2, prostacyclin
Fig. 1 A simplified depiction of sequence of events in an inflammatory response and the role of proresolution mediators in its termination. Tissue injury elicits an initial vascular response, followed by an influx of neutrophils and monocytes to the damaged area. After reaching the tissue, monocytes transform into macrophages and actively phagocytose the debris. Lymphocytes, which are cells of the adaptive immune system, later modulate this initial response. The basic mechanisms of resolution of inflammation are highlighted which are (1) lipid mediator class switching producing proresolution molecules such as lipoxins and resolvins; (2) increased efferocytosis by macrophages; (3) anti-inflammatory cytokines secreted by “resolving” macrophages and regulatory T cells. Failure to resolve leads to persistence of inflammation resulting in a chronic inflammatory state, causing sustained tissue injury. Adapted figure reproduced from [17] Buckley et al. 2014 with permission from the authors. PGE2, prostaglandin E2; PGI2, prostacyclinCC BY · PubMed Central
Fig. 2 Basic mechanisms of cardiac fibrosis highlighting the role of regulatory proteins in profibrotic signal modulation. ECM matrix deposition is the hallmark of fibrosis and myofibroblasts are the central cells in ECM synthesis. M2 macrophages also play a crucial role in fibrosis and influence ECM turnover chiefly by influencing MMP/TIMP proportions. There is extensive communication between these two cell types occurring through direct cell-cell interactions and also through paracrine signalling. In this diagram, we emphasize the central role of regulatory proteins, such as galectin-3 and syndecans, and how they can directly moderate fibrotic signalling between myofibroblasts and M2 macrophages. However, little is known about the interaction of regulatory proteins directly with ECM components and this could be the focus of future research. Two commonly occurring fibrotic scenarios in the heart are also depicted. In reactive fibrosis, cardiomyocyte death is usually the consequence of fibrosis; while in replacement fibrosis, cardiomyocyte death is the key driver of fibrosis. ECM, extracellular matrix
Fig. 2 Basic mechanisms of cardiac fibrosis highlighting the role of regulatory proteins in profibrotic signal modulation. ECM matrix deposition is the hallmark of fibrosis and myofibroblasts are the central cells in ECM synthesis. M2 macrophages also play a crucial role in fibrosis and influence ECM turnover chiefly by influencing MMP/TIMP proportions. There is extensive communication between these two cell types occurring through direct cell-cell interactions and also through paracrine signalling. In this diagram, we emphasize the central role of regulatory proteins, such as galectin-3 and syndecans, and how they can directly moderate fibrotic signalling between myofibroblasts and M2 macrophages. However, little is known about the interaction of regulatory proteins directly with ECM components and this could be the focus of future research. Two commonly occurring fibrotic scenarios in the heart are also depicted. In reactive fibrosis, cardiomyocyte death is usually the consequence of fibrosis; while in replacement fibrosis, cardiomyocyte death is the key driver of fibrosis. ECM, extracellular matrixCC BY · PubMed Central
Fig. 3 The interplay between systemic inflammation, cardiac inflammation and heart failure (HF) is highlighted. HF can arise de novo, for instance after myocardial infarction (MI) or can result from exacerbation of pre-existing HF. Long-standing systemic diseases such as hypertension, diabetes mellitus (DM) or obesity can also adversely affect cardiac function through various mechanisms (outside the rectangular box). HF is a systemic inflammatory state and promotes cardiac inflammation. Inflammation can affect cardiac function through several mechanisms such as (A) reduced contractility affecting mechanical properties of the heart, (B) cardiac stress leading up to cardiomyocyte death and (C) cardiac fibrosis. All these effects lead to HF or exacerbate pre-existing HF, and this is illustrated within the rectangular framework. Biomarkers and imaging can aid us in identifying the HF process early in the disease course and in assessing the nature of HF to choose appropriate therapeutic interventions. AHF, acute heart failure; ADHF, acute decompensated heart failure
Fig. 3 The interplay between systemic inflammation, cardiac inflammation and heart failure (HF) is highlighted. HF can arise de novo, for instance after myocardial infarction (MI) or can result from exacerbation of pre-existing HF. Long-standing systemic diseases such as hypertension, diabetes mellitus (DM) or obesity can also adversely affect cardiac function through various mechanisms (outside the rectangular box). HF is a systemic inflammatory state and promotes cardiac inflammation. Inflammation can affect cardiac function through several mechanisms such as (A) reduced contractility affecting mechanical properties of the heart, (B) cardiac stress leading up to cardiomyocyte death and (C) cardiac fibrosis. All these effects lead to HF or exacerbate pre-existing HF, and this is illustrated within the rectangular framework. Biomarkers and imaging can aid us in identifying the HF process early in the disease course and in assessing the nature of HF to choose appropriate therapeutic interventions. AHF, acute heart failure; ADHF, acute decompensated heart failureCC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 155 references

Cited by

See all 307

Metadata

Authors
Suthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A.
Affiliations
University Medical Center Groningen (NL)
Venue
Current Heart Failure Reports
Published
2017-07-13
Volume
14
Issue
4
Pages
235-250
ISSN
  • 1546-9530 (ISSN-L)
  • 1546-9549
OpenAlex
W2735815044
Cited by
307
References
155
Citations by year
2026: 15 · 2025: 29 · 2024: 35 · 2023: 34 · 2022: 30 · 2021: 54 · 2020: 57 · 2019: 27 · 2018: 24 · 2017: 2
FWCI
4.27
Type
journal article
Language
en
Open access
Locations
  • Current Heart Failure Reports (publishedVersion, cc-by)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • University of Groningen research database (University of Groningen / Centre for Information Technology) (submittedVersion, cc-by)
Funders
University of Groningen
Topics
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Congenital heart defects research
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Immunology Research
Keywords
cardiac inflammation, myocardial fibrosis, myocardial remodelling, heart failure, myocardial infarction, myocarditis, hypertension, therapeutic target, heart failure treatment
MeSH terms
Fibrosis, Heart Failure, Humans, Hypertension, Myocardial Infarction, Myocarditis, Myocardium, Ventricular Remodeling, Atrial Remodeling

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. https://app.cochat.ai/papers/10.1007/s11897-017-0343-y
The paper
Suthahar, N., Meijers, W. C., Silljé, H. H. W., & de Boer, R. A. (2017). From Inflammation to Fibrosis—Molecular and Cellular Mechanisms of Myocardial Tissue Remodelling and Perspectives on Differential Treatment Opportunities. Current Heart Failure Reports. https://doi.org/10.1007/s11897-017-0343-y

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.